Valink is a biotechnology company that specializes in the development of targeted cancer treatments using bispecific antibody-drug conjugates (bsADCs). They use a unique discovery platform to rapidly design and test new bsADCs with complex structures and diverse target and payload combinations.
No recent news for this company.